Feb 17, 2026 06:59AM
Nov 5, 2025 04:05PM
Feb 26, 2025 04:04PM
Dec 16, 2024 07:01AM
Dec 16, 2024 07:00AM
Oct 11, 2023 08:00AM
Sep 18, 2023 08:00AM XACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in
May 24, 2023 05:41AM
May 23, 2023 06:42PM
May 12, 2023 05:41AM
May 11, 2023 06:45PM
Apr 17, 2023 04:32PM
Apr 17, 2023 04:31PM
Mar 14, 2023 05:22AM Innoviva (INVA) Announces FDA Advisory Committee Meeting to Review Sulbactam-Durlobactam
Mar 13, 2023 06:24PM
Nov 30, 2022 04:30PM
Nov 30, 2022 04:30PM
Nov 9, 2022 04:05PM
Oct 19, 2022 08:01AM
Oct 19, 2022 08:00AM
Oct 19, 2022 08:00AM Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Presents Efficacy and Safety Data from Landmark Phase 3 ATTACK Trial at IDWEEK 2022
Oct 14, 2022 04:10PM
Oct 12, 2022 08:30AM
Oct 12, 2022 08:30AM
Sep 8, 2022 07:00AM
Aug 22, 2022 08:58AM
Aug 22, 2022 08:55AM
Jul 27, 2022 04:05PM Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress
Jul 14, 2022 12:45PM
Jul 13, 2022 04:25PM
Jul 13, 2022 04:25PM
Jul 11, 2022 09:19AM
Jul 11, 2022 09:17AM
Jul 11, 2022 09:17AM
Jul 11, 2022 07:32AM Innoviva to Acquire La Jolla Pharmaceutical Company
Jul 11, 2022 07:30AM
Jul 11, 2022 07:30AM
Jul 8, 2022 08:35AM
May 24, 2022 04:04PM
May 23, 2022 08:31AM
May 23, 2022 08:30AM
May 23, 2022 08:30AM Innoviva to Acquire Entasis Therapeutics
May 23, 2022 08:30AM
Apr 27, 2022 05:11PM
Feb 9, 2022 04:45PM
Jul 28, 2021 04:05PM
Apr 28, 2021 04:05PM
Mar 18, 2021 04:05PM
Feb 3, 2021 04:05PM Innoviva Reports Fourth Quarter 2020 Financial Results
Dec 13, 2018 07:30AM

1,154,948 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All